Coinbase, a provider of end-to-end financial infrastructure and technology for the cryptoeconomy, has acquired BRD, a crypto wallet firm. Homburger acted as Swiss counsel to Coinbase in this transaction. The Homburger team was led by
SIX listed SFS Group has entered into an agreement to join forces with and acquire 100 per cent of Hoffmann. The transaction does not include Contorion, the eCommerce subsidiary of Hoffmann, which is geared towards a
Baker McKenzie advised Deka Immobilien Investment (“Deka”) on its successful acquisition of the EK2 building, a major warehouse and logistics building near Geneva, from a Compagnie des Parcs subsidiary. The EK2 building is a ground
Deal & transactions
Real Estate
UBS sells Congress Hotel Seepark to Artisa Micro Living. The advisors
Artisa Micro Living, a Swiss company, active in the development and in the management of real estate investments in the Swiss and European markets, has successfully acquired the Congress Hotel Seepark and the related operating
Swiss law firm Lenz & Staehelin has appointed a team of four partners to form the newly elected National Management Committee. The team consisting of partners (pictured from left to right)) Heini Rüdisühli,
Kandou, an innovator in high-speed, energy-efficient, chip link solutions, closed its Series D round of funding, resulting in USD 75 million raised in the round. To date, the total investment in Kandou is USD 207.8 million from
La Vaudoise Group, through its subsidiary Vaudoise Asset Management, acquires a strategic stake of 20% in the holding company SEG Suisse Estate Group, listed on the Berne Stock Exchange. The main shareholders of SEG keep collectively
Numab Therapeutics, an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland, has named James Singleton (pictured) as its new general counsel. The Boston counsel will also serve on Numab’s Executive Management Team. Singleton most
Merck, a global science and technology company, has entered into an agreement to acquire Chord Therapeutics, a Swiss-based biotech company focused on rare neuroinflammatory diseases. With this step, Merck expands its neurology pipeline with the
MLL has accompanied VanEck ETP in the multicurrency listing of the VanEck Vectors Avalanche ETN (Ticker: VAVA) and the VanEck Vectors Polygon ETN (Ticker: VPOL) on the SIX Swiss Exchange. The new products are trading
